CEL, CPA1, and CPB1 code for carboxyl ester lipase, carboxypeptidase A1, and carboxypeptidase B1, respectively, and their downregulation is again indicative of pancreatic exocrine insufficiency associated with onset of malignancy in benign IPMNs. This evidence concerns the gene CPA1 and exocrine pancreatic insufficiency.